301363 美好医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.27210.10018.22224.23724.193
总资产报酬率 ROA (%)4.7469.06615.20318.78020.338
投入资产回报率 ROIC (%)5.0739.69316.82021.76923.321

边际利润分析
销售毛利率 (%)41.03141.19143.04344.90649.994
营业利润率 (%)27.80326.29432.27230.62533.139
息税前利润/营业总收入 (%)24.24322.37028.78831.34336.545
净利润/营业总收入 (%)23.94723.42328.41027.26329.053

收益指标分析
经营活动净收益/利润总额(%)97.89897.04898.181101.60695.722
价值变动净收益/利润总额(%)2.6684.4800.1871.0562.582
营业外收支净额/利润总额(%)-0.047-0.084-0.019-0.053-0.125

偿债能力分析
流动比率 (X)7.8498.6637.8922.8003.927
速动比率 (X)6.7147.2876.4811.9623.295
资产负债率 (%)10.2889.67810.83326.79616.702
带息债务/全部投入资本 (%)1.3102.1431.95311.8722.149
股东权益/带息债务 (%)7,378.6724,469.7154,923.764715.4804,486.088
股东权益/负债合计 (%)871.965933.270823.117273.192498.742
利息保障倍数 (X)-6.835-5.733-8.27842.69210.601

营运能力分析
应收账款周转天数 (天)64.95555.98053.30757.26852.712
存货周转天数 (天)155.183184.937166.977129.600104.317